BioLineRx Ltd. (BLRX)
2.216
+0.01
(+0.27%)
USD |
NASDAQ |
Oct 09, 16:00
2.22
0.00 (0.00%)
After-Hours: 20:00
BioLineRx Price to Book Value : 0.703 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 0.703 |
| October 08, 2026 | 0.7011 |
| October 07, 2026 | 0.6995 |
| October 06, 2026 | 0.7272 |
| October 05, 2026 | 0.736 |
| October 02, 2026 | 0.7518 |
| October 01, 2026 | 0.7455 |
| September 30, 2026 | 0.7455 |
| September 29, 2026 | 0.7487 |
| September 28, 2026 | 0.7709 |
| September 25, 2026 | 0.8248 |
| September 24, 2026 | 0.7994 |
| September 23, 2026 | 0.8121 |
| September 22, 2026 | 0.7709 |
| September 21, 2026 | 0.7867 |
| September 18, 2026 | 0.789 |
| September 17, 2026 | 0.8026 |
| September 16, 2026 | 0.7867 |
| September 15, 2026 | 0.7994 |
| September 14, 2026 | 0.7709 |
| September 11, 2026 | 0.7963 |
| September 10, 2026 | 0.8151 |
| September 09, 2026 | 0.809 |
| September 08, 2026 | 0.8216 |
| September 04, 2026 | 0.847 |
| Date | Value |
|---|---|
| September 03, 2026 | 0.8534 |
| September 02, 2026 | 0.8692 |
| September 01, 2026 | 0.8756 |
| August 31, 2026 | 0.8883 |
| August 28, 2026 | 0.8248 |
| August 27, 2026 | 0.8756 |
| August 26, 2026 | 0.8565 |
| August 25, 2026 | 0.9041 |
| August 24, 2026 | 0.9517 |
| August 21, 2026 | 0.8914 |
| August 20, 2026 | 0.8756 |
| August 19, 2026 | 0.9295 |
| August 18, 2026 | 0.9041 |
| August 17, 2026 | 0.8375 |
| August 14, 2026 | 0.8756 |
| August 13, 2026 | 0.8625 |
| August 12, 2026 | 0.8534 |
| August 11, 2026 | 0.8803 |
| August 10, 2026 | 0.8603 |
| August 07, 2026 | 0.8597 |
| August 06, 2026 | 0.8851 |
| August 05, 2026 | 0.8619 |
| August 04, 2026 | 0.8756 |
| August 03, 2026 | 0.8429 |
| July 31, 2026 | 0.8946 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.729 |
| Can-Fite BioPharma Ltd. | 1.380 |
| Eocene Ltd. | 0.2783 |
| Revium Recovery, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 6.958 |
| PEG Ratio | -0.025 |
| Price | 2.216 |
| Earnings Yield | -82.09% |
| Market Cap | 9.680M |
| PEGY Ratio | -0.025 |